{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:58:26Z","timestamp":1790801906867,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"DOI":"10.1038\/s41440-026-02795-2","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:56:31Z","timestamp":1789098991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adipocyte-specific deletion of adrenomedullin exacerbates high-fat diet-induced hypertension"],"prefix":"10.1038","author":[{"given":"Miku","family":"Oya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosai","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Inazumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Nishikimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeya","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kangawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2795_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","volume":"192","author":"K Kitamura","year":"1993","unstructured":"Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"2795_CR2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1006\/bbrc.1994.1827","volume":"201","author":"S Sugo","year":"1994","unstructured":"Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994;201:1160\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2795_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1006\/bbrc.1994.2241","volume":"203","author":"S Sugo","year":"1994","unstructured":"Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun. 1994;203:719\u201326.","journal-title":"Biochem Biophys Res Commun"},{"key":"2795_CR4","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1291\/hypres.26.S109","volume":"26","author":"T Shimosawa","year":"2003","unstructured":"Shimosawa T, Matsui H, Xing G, Itakura K, Ando K, Fujita T. Organ-protective effects of adrenomedullin. Hypertens Res. 2003;26:S109\u201312.","journal-title":"Hypertens Res"},{"key":"2795_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41440-021-00806-y","volume":"45","author":"T Kita","year":"2022","unstructured":"Kita T, Kitamura K. Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases. Hypertens Res. 2022;45:389\u2013400.","journal-title":"Hypertens Res"},{"key":"2795_CR6","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1172\/JCI117573","volume":"94","author":"T Ishimitsu","year":"1994","unstructured":"Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest. 1994;94:2158\u201361.","journal-title":"J Clin Invest"},{"key":"2795_CR7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/0735-1097(95)00338-X","volume":"26","author":"T Nishikimi","year":"1995","unstructured":"Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 1995;26:1424\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"2795_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.hfc.2017.08.006","volume":"14","author":"T Nishikimi","year":"2018","unstructured":"Nishikimi T, Nakagawa Y. Adrenomedullin as a Biomarker of Heart Failure. Heart Fail Clin. 2018;14:49\u201355.","journal-title":"Heart Fail Clin"},{"key":"2795_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/hrt.79.1.39","volume":"79","author":"Y Miyao","year":"1998","unstructured":"Miyao Y, Nishikimi T, Goto Y, Miyazaki S, Daikoku S, Morii I, et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart. 1998;79:39\u201344.","journal-title":"Heart"},{"key":"2795_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/cs0960033","volume":"96","author":"M Kakishita","year":"1999","unstructured":"Kakishita M, Nishikimi T, Okano Y, Satoh T, Kyotani S, Nagaya N, et al. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci. 1999;96:33\u20139.","journal-title":"Clin Sci"},{"key":"2795_CR11","doi-asserted-by":"crossref","unstructured":"Nishikimi T, Kinoshita H, Inazumi H, Kanamori T, Yanagisawa H, Moriuchi K, et al. Adrenomedullin in pulmonary hypertension. Dan Med J. 2024;71:A07240498.","DOI":"10.61409\/A07240498"},{"key":"2795_CR12","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1291\/hypres.26.S41","volume":"26","author":"Y Li","year":"2003","unstructured":"Li Y, Totsune K, Takeda K, Furuyama K, Shibahara S, Takahashi K. Decreased expression of adrenomedullin during adipocyte-differentiation of 3T3-L1 cells. Hypertens Res. 2003;26:S41\u20134.","journal-title":"Hypertens Res"},{"key":"2795_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.regpep.2005.07.006","volume":"132","author":"T Nambu","year":"2005","unstructured":"Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N, et al. Expression of the adrenomedullin gene in adipose tissue. Regul Pept. 2005;132:17\u201322.","journal-title":"Regul Pept"},{"key":"2795_CR14","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.1152\/ajpendo.00586.2003","volume":"288","author":"N Fukai","year":"2005","unstructured":"Fukai N, Yoshimoto T, Sugiyama T, Ozawa N, Sato R, Shichiri M, et al. Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues. Am J Physiol Endocrinol Metab. 2005;288:E56\u201362.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2795_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1530\/eje.1.02170","volume":"155","author":"O Paulmyer-Lacroix","year":"2006","unstructured":"Paulmyer-Lacroix O, Desbriere R, Poggi M, Achard V, Alessi MC, Boudouresque F, et al. Expression of adrenomedullin in adipose tissue of lean and obese women. Eur J Endocrinol. 2006;155:177\u201385.","journal-title":"Eur J Endocrinol"},{"key":"2795_CR16","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1097\/00005344-200000006-00018","volume":"36","author":"J Minami","year":"2000","unstructured":"Minami J, Nishikimi T, Ishimitsu T, Makino Y, Kawano Y, Takishita S, et al. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol. 2000;36:S83\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2795_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991\u20131006.","journal-title":"Circ Res"},{"key":"2795_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-025-00950-5","volume":"21","author":"N Ahmed","year":"2025","unstructured":"Ahmed N, Dalmasso C, Turner MB, Arthur G, Cincinelli C, Loria AS. From fat to filter: the effect of adipose tissue-derived signals on kidney function. Nat Rev Nephrol. 2025;21:417\u201334.","journal-title":"Nat Rev Nephrol"},{"key":"2795_CR19","first-page":"1016","volume":"85","author":"JG Lainchbury","year":"2000","unstructured":"Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab. 2000;85:1016\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"2795_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/hc0102.101399","volume":"105","author":"T Shimosawa","year":"2002","unstructured":"Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation. 2002;105:106\u201311.","journal-title":"Circulation"},{"key":"2795_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/CIRCRESAHA.121.318898","volume":"130","author":"H Inazumi","year":"2022","unstructured":"Inazumi H, Kuwahara K, Nakagawa Y, Kuwabara Y, Numaga-Tomita T, Kashihara T, et al. NRSF-GNAO1 Pathway Contributes to the Regulation of Cardiac Ca(2+) Homeostasis. Circ Res. 2022;130:234\u201348.","journal-title":"Circ Res"},{"key":"2795_CR22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/01.HYP.33.5.1146","volume":"33","author":"A Morimoto","year":"1999","unstructured":"Morimoto A, Nishikimi T, Yoshihara F, Horio T, Nagaya N, Matsuo H, et al. Ventricular Adrenomedullin Levels Correlate With the Extent of Cardiac Hypertrophy in Rats. Hypertension. 1999;33:1146\u201352.","journal-title":"Hypertension"},{"key":"2795_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cardiores.2004.12.014","volume":"66","author":"T Nishikimi","year":"2005","unstructured":"Nishikimi T, Hagaman JR, Takahashi N, Kim HS, Matsuoka H, Smithies O, et al. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. Cardiovasc Res. 2005;66:94\u2013103.","journal-title":"Cardiovasc Res"},{"key":"2795_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.adr4731","volume":"387","author":"H Cho","year":"2025","unstructured":"Cho H, Lai C-C, Bonnavion R, Alnouri MW, Wang S, Roquid KA, et al. Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. Science. 2025;387:674\u201382.","journal-title":"Science"},{"key":"2795_CR25","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1038\/s41440-024-01701-y","volume":"47","author":"SY Liu","year":"2024","unstructured":"Liu SY, Wang Q, Zhou H, Tong N, Chang R, Wang FZ, et al. Adrenomedullin improved endothelial dysfunction via receptor-Akt pathway in rats with obesity-related hypertension. Hypertens Res. 2024;47:2157\u201371.","journal-title":"Hypertens Res"},{"key":"2795_CR26","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1161\/01.CIR.101.19.2309","volume":"101","author":"T Shindo","year":"2000","unstructured":"Shindo T, Kurihara H, Maemura K, Kurihara Y, Kuwaki T, Izumida T, et al. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation. 2000;101:2309\u201316.","journal-title":"Circulation"},{"key":"2795_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0014-2999(98)00475-0","volume":"355","author":"F Yoshihara","year":"1998","unstructured":"Yoshihara F, Nishikimi T, Horio T, Yutani C, Takishita S, Matsuo H, et al. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol. 1998;355:33\u20139.","journal-title":"Eur J Pharmacol"},{"key":"2795_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/01.CIR.0000136085.34185.83","volume":"110","author":"R Nakamura","year":"2004","unstructured":"Nakamura R, Kato J, Kitamura K, Onitsuka H, Imamura T, Cao Y, et al. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats. Circulation. 2004;110:426\u201331.","journal-title":"Circulation"},{"key":"2795_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0167-0115(03)00021-1","volume":"112","author":"CJ Charles","year":"2003","unstructured":"Charles CJ, Lainchbury JG, Nicholls MG, Rademaker MT, Richards AM, Troughton RW. Adrenomedullin and the renin-angiotensin-aldosterone system. Regul Pept. 2003;112:41\u20139.","journal-title":"Regul Pept"},{"key":"2795_CR30","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1161\/01.HYP.29.5.1148","volume":"29","author":"BL Jensen","year":"1997","unstructured":"Jensen BL, Kr\u00e4mer BK, Kurtz A. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension. 1997;29:1148\u201355.","journal-title":"Hypertension"},{"key":"2795_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/01.HYP.28.2.308","volume":"28","author":"T Yamaguchi","year":"1996","unstructured":"Yamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. Hypertension. 1996;28:308\u201314.","journal-title":"Hypertension"},{"key":"2795_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0024-3205(94)00903-1","volume":"56","author":"T Yamaguchi","year":"1995","unstructured":"Yamaguchi T, Baba K, Doi Y, Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci. 1995;56:379\u201387.","journal-title":"Life Sci"},{"key":"2795_CR33","first-page":"R1289","volume":"269","author":"M Fukuhara","year":"1995","unstructured":"Fukuhara M, Tsuchihashi T, Abe I, Fujishima M. Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol. 1995;269:R1289\u201393.","journal-title":"Am J Physiol"},{"key":"2795_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/01.HYP.0000165690.85505.37","volume":"45","author":"M Fujita","year":"2005","unstructured":"Fujita M, Kuwaki T, Ando K, Fujita T. Sympatho-inhibitory action of endogenous adrenomedullin through inhibition of oxidative stress in the brain. Hypertension. 2005;45:1165\u201372.","journal-title":"Hypertension"},{"key":"2795_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/01.HYP.28.3.325","volume":"28","author":"T Shimosawa","year":"1996","unstructured":"Shimosawa T, Fujita T. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension. 1996;28:325\u20139.","journal-title":"Hypertension"},{"key":"2795_CR36","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1172\/JCI118208","volume":"96","author":"T Shimosawa","year":"1995","unstructured":"Shimosawa T, Ito Y, Ando K, Kitamura K, Kangawa K, Fujita T. Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest. 1995;96:1672\u20136.","journal-title":"J Clin Invest"},{"key":"2795_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/hy0901.096422","volume":"38","author":"RM Carey","year":"2001","unstructured":"Carey RM. Renal Dopamine System. Hypertension. 2001;38:297\u2013302.","journal-title":"Hypertension"},{"key":"2795_CR38","first-page":"F28","volume":"258","author":"M Hayashi","year":"1990","unstructured":"Hayashi M, Yamaji Y, Kitajima W, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol. 1990;258:F28\u201333.","journal-title":"Am J Physiol"},{"key":"2795_CR39","first-page":"F795","volume":"254","author":"A Bertorello","year":"1988","unstructured":"Bertorello A, H\u00f6kfelt T, Goldstein M, Aperia A. Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol. 1988;254:F795\u2013801.","journal-title":"Am J Physiol"},{"key":"2795_CR40","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1172\/JCI57324","volume":"121","author":"MZ Zhang","year":"2011","unstructured":"Zhang MZ, Yao B, Wang S, Fan X, Wu G, Yang H, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest. 2011;121:2845\u201354.","journal-title":"J Clin Invest"},{"key":"2795_CR41","doi-asserted-by":"crossref","unstructured":"Yoon Y, Duffy SR, Kirk SE, Promnares K, Karki P, Birukova AA, et al. Adrenomedullin-RAMP2 Enhances Lung Endothelial Cell Homeostasis Under Shear Stress. Cells. 2026;15:152.","DOI":"10.3390\/cells15020152"},{"key":"2795_CR42","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1291\/hypres.26.S99","volume":"26","author":"H Okumura","year":"2003","unstructured":"Okumura H, Nagaya N, Kangawa K. Adrenomedullin infusion during ischemia\/reperfusion attenuates left ventricular remodeling and myocardial fibrosis in rats. Hypertens Res. 2003;26:S99\u2013104.","journal-title":"Hypertens Res"},{"key":"2795_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11906-014-0452-x","volume":"16","author":"S Ogura","year":"2014","unstructured":"Ogura S, Shimosawa T. Oxidative stress and organ damages. Curr Hypertens Rep. 2014;16:452.","journal-title":"Curr Hypertens Rep"},{"key":"2795_CR44","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/01.HYP.0000066846.46422.2C","volume":"41","author":"T Shimosawa","year":"2003","unstructured":"Shimosawa T, Ogihara T, Matsui H, Asano T, Ando K, Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension. 2003;41:1080\u20135.","journal-title":"Hypertension"},{"key":"2795_CR45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/0002-9343(72)90050-2","volume":"52","author":"AC Guyton","year":"1972","unstructured":"Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972;52:584\u201394.","journal-title":"Am J Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02795-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:03:14Z","timestamp":1790798594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02795-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":45,"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02795-2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Honoraria: K. Kuwahara (Astellas Pharma Inc., AstraZeneca K.K., MSD K.K., Otsuka Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Kowa Co., Ltd., Sanofi K.K., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corp., Eli Lilly Japan K.K., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Bayer Yakuhin, Ltd., Pfizer Japan Inc., Janssen Pharmaceutical K.K.); H. Kinoshita (Nippon Shinyaku Co., Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., MSD K.K.); K. Ono (Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Pfizer Inc., Kowa Co., Ltd., Amgen K.K., Otsuka Pharmaceutical Co., Ltd., AstraZeneca K.K., Tsumura & Co., Mochida Pharmaceutical Co., Ltd.). Research funding: K. Kuwahara (Kowa Co., Ltd., AstraZeneca K.K., Daiichi Sankyo Co., Ltd., Novo Nordisk Pharma Ltd., Amgen, Janssen Pharmaceutical K.K., Parexel International Inc., Astellas Pharma Inc.); K. Ono (Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Pfizer Inc., Kowa Co., Ltd., Amgen K.K., Otsuka Pharmaceutical Co., Ltd., AstraZeneca K.K., Tsumura & Co., Mochida Pharmaceutical Co., Ltd.). Scholarship or donation: K. Kuwahara\u2019s affiliated institution, Shinshu University School of Medicine (Otsuka Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corp., Nippon Boehringer Ingelheim Co., Ltd., Kyowa Kirin Co., Ltd.). Endowed departments: K. Kuwahara\u2019s department has endowed chairs from Medtronic Japan Co., Ltd., Boston Scientific Japan K.K., Abbott Japan LLC, Japan Lifeline Co., Ltd., Biotronik Japan, Terumo Corporation, Nipro Corporation, and Cordis Japan G.K. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}